Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Evelo Biosciences stock

Learn how to easily invest in Evelo Biosciences stock.

Evelo Biosciences is a biotechnology business based in the US. Evelo Biosciences shares (EVLO) are listed on the NASDAQ and all prices are listed in US Dollars. Evelo Biosciences employs 66 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Evelo Biosciences stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – EVLO. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Evelo Biosciences stock price (NASDAQ: EVLO)

Use our graph to track the performance of EVLO stocks over time.

Evelo Biosciences shares at a glance

Information last updated 2023-03-24.
Latest market close$0.20
52-week range$0.20 - $4.36
50-day moving average $0.76
200-day moving average $1.76
Wall St. target price$1.40
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.16

Buy Evelo Biosciences stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $10,000 - $250,000+
Stocks, Bonds, Options, Mutual funds, ETFs, Futures
Get up to $600 or more
when you open and fund a new account.
E*TRADE offers commission-free stocks, access to mutual funds and advanced trading tools. Other fees apply.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Evelo Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Evelo Biosciences price performance over time

Historical closes compared with the close of $0.196 from 2023-03-29

1 week (2023-03-23) -4.72%
1 month (2023-03-02) -64.84%
3 months (2022-12-30) -87.83%
6 months (2022-09-30) -90.62%
1 year (2022-03-26) N/A
2 years (2021-03-30) -98.11%
3 years (2020-03-30) 3.85
5 years (2018-03-26) N/A

Evelo Biosciences financials

Gross profit TTM $0
Return on assets TTM -89.02%
Return on equity TTM -6232.76%
Profit margin 0%
Book value $-0.05
Market capitalisation $25.1 million

TTM: trailing 12 months

Evelo Biosciences share dividends

We're not expecting Evelo Biosciences to pay a dividend over the next 12 months.

Evelo Biosciences share price volatility

Over the last 12 months, Evelo Biosciences's shares have ranged in value from as little as $0.2 up to $4.36. A popular way to gauge a stock's volatility is its "beta".

EVLO.US volatility(beta: 1.38)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evelo Biosciences's is 1.377. This would suggest that Evelo Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Evelo Biosciences overview

Evelo Biosciences, Inc. , a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. .

Frequently asked questions

What percentage of Evelo Biosciences is owned by insiders or institutions?
Currently 0.127% of Evelo Biosciences shares are held by insiders and 83.687% by institutions.
How many people work for Evelo Biosciences?
Latest data suggests 66 work at Evelo Biosciences.
When does the fiscal year end for Evelo Biosciences?
Evelo Biosciences's fiscal year ends in December.
Where is Evelo Biosciences based?
Evelo Biosciences's address is: 620 Memorial Drive, Cambridge, MA, United States, 02139
What is Evelo Biosciences's ISIN number?
Evelo Biosciences's international securities identification number is: US2997341035
What is Evelo Biosciences's CUSIP number?
Evelo Biosciences's Committee on Uniform Securities Identification Procedures number is: 299734103

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site